{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:56:50Z","timestamp":1791633410452,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017244","name":"Military Institute of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017244","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis, usually seronegative and associated with psoriasis (Ps). The prevalence and incidence of psoriatic arthritis show strong ethnic and geographic variations. The aim of the study was to assess the epidemiological trends in psoriatic arthritis in Poland. The National Health Fund (NHF) database for the period 2008\u20132018 was analyzed. PsA was defined as ICD-10 codes L40.5, M07, M07.0, M07.1, M07.2 and M07.3, while psoriasis as ICD-10 codes L40 and L40.X (L40.0 to L40.9). A steady increase in the number of PsA patients (from 16,790 to 32,644) and in PsA recorded prevalence (from 38.47 per 100,000 in 2008 to 73.11 per 100,000 in 2018) was observed between 2008 and 2018. The PsA\/Ps ratio increased to a similar extent (from 8.3 to 17.5%). The percentage of PsA patients receiving rehabilitation services remained constant throughout the observation period (mean: 17.35%; range 16.7\u201318.9%). The study showed a steady and continuous increase in PsA recorded prevalence. A simultaneous increase in the PsA\/Ps ratio suggests that the main reason for the observed trend is greater disease detection .<\/jats:p>","DOI":"10.1007\/s00296-020-04734-x","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T11:25:36Z","timestamp":1603884336000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Trends in psoriatic arthritis epidemiology in Poland"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-7227","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"T\u0142ustochowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8134-2955","authenticated-orcid":false,"given":"Waldemar","family":"Wierzba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-0529","authenticated-orcid":false,"given":"Micha\u0142","family":"Marczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-2901","authenticated-orcid":false,"given":"Witold","family":"T\u0142ustochowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0239-1637","authenticated-orcid":false,"given":"Andrzej","family":"\u015aliwczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-0260","authenticated-orcid":false,"given":"Filip","family":"Raciborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-1830","authenticated-orcid":false,"given":"Brygida","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3762-9254","authenticated-orcid":false,"given":"Melania","family":"Brzozowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-6245","authenticated-orcid":false,"given":"Andrzej","family":"Jacyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6311-0475","authenticated-orcid":false,"given":"Bart\u0142omiej","family":"Kisiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"4734_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00296-019-04287-8","volume":"39","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska M, Dobrzy\u0144ski T, Kwiatkowska B (2019) Rheumatology in Poland. Rheumatol Int 39:757\u2013767. https:\/\/doi.org\/10.1007\/s00296-019-04287-8","journal-title":"Rheumatol Int"},{"key":"4734_CR2","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.2165\/00003495-200262170-00004","volume":"62","author":"J Brockbank","year":"2002","unstructured":"Brockbank J, Gladman D (2002) Diagnosis and management of psoriatic arthritis. Drugs 62:2447\u20132457. https:\/\/doi.org\/10.2165\/00003495-200262170-00004","journal-title":"Drugs"},{"key":"4734_CR3","first-page":"1842","volume":"28","author":"KB Sokoll","year":"2001","unstructured":"Sokoll KB, Helliwell PS (2001) Comparison of disability and quality of life in rheumatoid arthritis and psoriatic arthritis. J Rheumatol 28:1842\u20131846","journal-title":"J Rheumatol"},{"key":"4734_CR4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735\u20131741. https:\/\/doi.org\/10.1001\/jama.296.14.1735","journal-title":"JAMA"},{"key":"4734_CR5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/j.1468-3083.2012.04706.x","volume":"27","author":"YY Chin","year":"2013","unstructured":"Chin YY, Yu HS, Li WC, Ko YC, Chen GS, Wu CS et al (2013) Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nationwide study. J Eur Acad Dermatol Venereol 27:1262\u20131268. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04706.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4734_CR6","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/art.1780401021","volume":"40","author":"K Wong","year":"1997","unstructured":"Wong K, Gladman DD, Husted J, Long JA, Farewell VT (1997) Mortality studies in psoriatic arthritis; results from a single outpatient clinic, I: causes and risk of death. Arthritis Rheum 40:1868\u20131872. https:\/\/doi.org\/10.1002\/art.1780401021","journal-title":"Arthritis Rheum"},{"key":"4734_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","volume":"41","author":"DD Gladman","year":"1998","unstructured":"Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis; results from a single outpatient center, II: prognostic indicators for death. Arthritis Rheum 41:1103\u20131110. https:\/\/doi.org\/10.1002\/1529-0131(199806)41:6%3c1103:AID-ART18%3e3.0.CO;2-N","journal-title":"Arthritis Rheum"},{"key":"4734_CR8","doi-asserted-by":"publisher","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","volume":"34","author":"V Chandran","year":"2010","unstructured":"Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314\u2013J321. https:\/\/doi.org\/10.1016\/j.jaut.2009.12.001","journal-title":"J Autoimmun"},{"key":"4734_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.berh.2018.09.006","volume":"32","author":"D Solmaz","year":"2018","unstructured":"Solmaz D, Eder L, Aydin SZ (2018) Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis. Best Pract Res Clin Rheumatol 32:295\u2013311. https:\/\/doi.org\/10.1016\/j.berh.2018.09.006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4734_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","volume":"48","author":"L Scotti","year":"2018","unstructured":"Scotti L, Franchi M, Marchesoni A, Corrao G (2018) Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 48:28\u201334. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.003","journal-title":"Semin Arthritis Rheum"},{"key":"4734_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5114\/reum.2016.64902","volume":"54","author":"F Raciborski","year":"2016","unstructured":"Raciborski F, \u015aliwczy\u0144ski A, K\u0142ak A, Kwiatkowska B, Brzozowska M, T\u0142ustochowicz M (2016) Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland. Reumatologia 54:278\u2013284. https:\/\/doi.org\/10.5114\/reum.2016.64902","journal-title":"Reumatologia"},{"key":"4734_CR12","unstructured":"https:\/\/www.europarl.europa.eu\/meetdocs\/2009_2014\/documents\/ com\/com_com%282012%290011_\/com_com%282012%29001 1_pl.pdf. Accessed 09 July 2014"},{"key":"4734_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 41:545\u2013568. https:\/\/doi.org\/10.1016\/j.rdc.2015.07.001","journal-title":"Rheum Dis Clin North Am"},{"issue":"71","key":"4734_CR14","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/acr.23743","volume":"2019","author":"L Eder","year":"2019","unstructured":"Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R et al (2019) Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: a population-based study. Arthritis Care Res (Hoboken) 2019(71):1084\u20131091. https:\/\/doi.org\/10.1002\/acr.23743","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4734_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM, Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133:377\u2013385. https:\/\/doi.org\/10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"issue":"5","key":"4734_CR16","doi-asserted-by":"publisher","first-page":"e98024","DOI":"10.1371\/journal.pone.0098024","volume":"9","author":"S L\u04e7fvendahl","year":"2014","unstructured":"L\u04e7fvendahl S, Theander E, Svensson A, Carlsson KS, Englund M, Petersson IF (2014) Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in Southern Sweden\u2014A population-based register study. PLoS ONE 9(5):e98024. https:\/\/doi.org\/10.1371\/journal.pone.0098024","journal-title":"PLoS ONE"},{"key":"4734_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13075-017-1497-4","volume":"20","author":"L Eder","year":"2018","unstructured":"Eder L, Cohen AD, Feldhamer I, Greenberg-Dotan S, Batat E, Zisman D (2018) The epidemiology of psoriatic arthritis in Israel\u2014a population-based study. Arthritis Res Ther 20:3. https:\/\/doi.org\/10.1186\/s13075-017-1497-4","journal-title":"Arthritis Res Ther"},{"key":"4734_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2018","unstructured":"Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D et al (2018) Prevalence of psoriatic arthritis in patients with psoriasis: a systemic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80:251\u2013265. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.027","journal-title":"J Am Acad Dermatol"},{"key":"4734_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","volume":"73","author":"AP Villani","year":"2015","unstructured":"Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA et al (2015) Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 73:242\u2013248. https:\/\/doi.org\/10.1016\/j.jaad.2015.05.001","journal-title":"J Am Acad Dermatol"},{"key":"4734_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, Khraishi MM, Tha\u00e7i D, Behrens F et al (2013) Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American Dermatology Clinics. J Am Acad Dermatol 69:729\u2013735. https:\/\/doi.org\/10.1016\/j.jaad.2013.07.023","journal-title":"J Am Acad Dermatol"},{"key":"4734_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6\u00a0months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74:1045\u20131050. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204858","journal-title":"Ann Rheum Dis"},{"key":"4734_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-019-0102-7","volume":"4","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Nowell WB, Applegate E, Gavigan K, Venkatachalam S, de la Cruz M et al (2020) Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States. BMC Rheumatol 4:2. https:\/\/doi.org\/10.1186\/s41927-019-0102-7","journal-title":"BMC Rheumatol"},{"key":"4734_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"LC Coates","year":"2016","unstructured":"Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Acosta-Felquer ML, Armstrong AW et al (2016) Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 68:1060\u20131071. https:\/\/doi.org\/10.1002\/art.39573","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-020-04734-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04734-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T04:18:11Z","timestamp":1610597891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-020-04734-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4734"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04734-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no confict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this study, ethical approval is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients\u2019 written informed consent was not needed, as this was a retrospective type of study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}